Taken together, these results show that YAP/TAZ are key factors in initiating the transformation of astroglial cells, and their inhibition can prevent one of the main obstacles to the treatment of glioblastoma, which is the presence of cells with stem phenotypes that are resistant to treatment (Figure 2). The gene discussed is YAP1; the disease is glioblastoma.